home / stock / crmd / crmd news

CRMD News and Press, CorMedix Inc. From 05/16/20

Stock Information
Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com
Menu
CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...
CRMD - Stocks To Watch: Retail Heavyweights, Nvidia, Bristol-Myers And 5G Plays

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
CRMD - CorMedix, Inc. (CRMD) CEO Khoso Baluch on Q1 2020 Results - Earnings Call Transcript

CorMedix, Inc. (CRMD) Q1 2020 Earnings Conference Call May 11, 2020, 16:30 ET Company Participants Daniel Ferry - LifeSci Advisors Khoso Baluch - CEO & Director Matt David - EVP & CFO Phoebe Mounts - EVP, General Counsel, Secretary & Head, Regulatory, Compliance and...

CRMD - CorMedix EPS beats by $0.02, misses on revenue

CorMedix (NYSEMKT: CRMD ): Q1 GAAP EPS of -$0.21 beats by $0.02 . Revenue of $0.07M (-56.3% Y/Y) misses by $0.18M . Press Release More news on: CorMedix, Inc., Earnings news and commentary, Healthcare stocks news, ,

CRMD - CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced financial results...
CRMD - CorMedix Inc. Announces Appointment of Chief Financial Officer

BERKELEY HEIGHTS, N.J., May 11, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American:  CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has...

CRMD - CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®

BERKELEY HEIGHTS, N.J., May 06, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, will host a call with Key Opinion...

CRMD - CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11

BERKELEY HEIGHTS, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will repo...
CRMD - CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations

BERKELEY HEIGHTS, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has ent...

CRMD - CorMedix Completes Sale of $5.5 Million of NOL Tax Benefits through New Jersey Technology Business Tax Certificate Transfer Program

BERKELEY HEIGHTS, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has com...

CRMD - CorMedix, Inc. (CRMD) CEO Khoso Baluch on Q4 2019 Results - Earnings Call Transcript

CorMedix, Inc. (CRMD) Q4 2019 Earnings Conference Call March 16, 2020 4:30 PM ET Company Participants Dan Ferry - Managing Director, LifeSci Advisors Khoso Baluch - Chief Executive Officer Phoebe Mounts - Executive Vice President and General Counsel Conference Call Participan...
Previous 10 Next 10